EXCESS MORTALITY IN PATIENTS WITH ADVANCED CHRONIC HEPATITIS C TREATED WITH LONG-TERM PEGINTERFERON

BACKGROUND/AIMS: Chronic hepatitis C virus infection can cause chronic liver disease, cirrhosis and liver cancer. The HALT-C Trial was a prospective, randomized controlled study of long-term, low-dose peginterferon therapy in patients with advanced chronic hepatitis C who had failed to respond to a...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Di Bisceglie, Adrian M., Stoddard, Anne M., Dienstag, Jules L., Shiffman, Mitchell L., Seeff, Leonard B., Bonkovsky, Herbert L., Morishima, Chihiro, Wright, Elizabeth C., Snow, Kristin K., Lee, William M., Fontana, Robert J., Morgan, Timothy R., Ghany, Marc G.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2011
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3073857/
https://ncbi.nlm.nih.gov/pubmed/21480316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.24169
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन